Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Claudia Kohring"'
Autor:
Christopher Rohde, Christian Otte, Woo Ri Chae, Ole Köhler-Forsberg, Claudia Kohring, Jakob Holstiege
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 12, Iss 3 (2024)
Introduction Research linking type 2 diabetes and depression mostly relied on hospital-based diagnoses or prescription data, overlooking many outpatient diagnoses. We aimed to quantify the risks of depression in individuals newly diagnosed with type
Externí odkaz:
https://doaj.org/article/4d08cf6217fa4a738827ce03f009aa49
Trends in incidence of atopic disorders in children and adolescents - Analysis of German claims data
Autor:
Claudia Kohring, MSc, Manas K. Akmatov, PhD, Lotte Dammertz, MSc, Joachim Heuer, Dipl-Vw, Jörg Bätzing, MD, Jakob Holstiege, PhD
Publikováno v:
World Allergy Organization Journal, Vol 16, Iss 7, Pp 100797- (2023)
Background: This claims-based study aimed to assess recent nationwide trends in pediatric incidence of atopic diseases in Germany. Methods: Incidence of atopic dermatitis, asthma, and hay fever was assessed from 2013 to 2021 in annual cohorts of 0- t
Externí odkaz:
https://doaj.org/article/a28c09b858034523853a514f652395bb
Autor:
Jakob Holstiege, Manas K. Akmatov, Claudia Kohring, Lotte Dammertz, Frank Ng, Thomas Czihal, Dominik von Stillfried, Jörg Bätzing
Publikováno v:
BMC Public Health, Vol 21, Iss 1, Pp 1-11 (2021)
Abstract Background Research has shown that the risk for a severe course of COVID-19 is increased in the elderly population and among patients with chronic conditions. The aim of this study was to provide estimates of the size of vulnerable populatio
Externí odkaz:
https://doaj.org/article/441aa06679d34b88a873f10bcf586062
Autor:
Manas K. Akmatov, Claudia Kohring, Lotte Dammertz, Joachim Heuer, Maike Below, Jörg Bätzing, Jakob Holstiege
Publikováno v:
Antibiotics, Vol 11, Iss 10, p 1433 (2022)
The aim of the study was to examine whether the COVID-19 pandemic had any effect on antibiotic prescription rates in children in Germany. Using the nationwide outpatient prescription data from the Statutory Health Insurance from 2010 to 2021, changes
Externí odkaz:
https://doaj.org/article/4bddf1cf8ba44801a34a5a93e94617d6
Autor:
Karsten Keller, Claudia Kohring, Ioannis T. Farmakis, Luca Valerio, Stefano Barco, Jörg Bätzing, Manas K. Akmatov, Stavros Konstantinides, Thomas Münzel, Lukas Hobohm, Jakob Holstiege
Publikováno v:
Thrombosis Research. 226:9-17
Autor:
Manas K Akmatov, Jakob Holstiege, Lotte Dammertz, Joachim Heuer, Claudia Kohring, Jörg Bätzing
Publikováno v:
Journal of Asthma and Allergy. 15:1205-1215
Manas K Akmatov,* Jakob Holstiege,* Lotte Dammertz, Joachim Heuer, Claudia Kohring, Jörg Bätzing Department of Epidemiology and Health Care Atlas, Central Research Institute of Ambulatory Health Care, Berlin, Germany*These authors c
Autor:
Thomas Czihal, Lotte Dammertz, Manas K. Akmatov, Jörg Bätzing, Dominik von Stillfried, Claudia Kohring, Jakob Holstiege, Frank Ng
Publikováno v:
BMC Public Health, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Public Health
BMC Public Health
Background Research has shown that the risk for a severe course of COVID-19 is increased in the elderly population and among patients with chronic conditions. The aim of this study was to provide estimates of the size of vulnerable populations at hig
Autor:
Manas K Akmatov, Jakob Holstiege, Lotte Dammertz, Joachim Heuer, Claudia Kohring, Martin Lotto-Batista, Friedrich Boeing, Stéphane Ghozzi, Stefanie Castell, Jörg Bätzing
Publikováno v:
Eurosurveillance. 27
Introduction Evidence of nationwide and regional morbidity of Lyme borreliosis (LB) in Germany is lacking. Aims We calculated the total number of incident LB cases in Germany in 2019, compared regional variations, investigated the extent of possible
Autor:
Jakob, Holstiege, Manas K, Akmatov, Kerstin, Klimke, Lotte, Dammertz, Claudia, Kohring, Christine, Marx, Niklas, Frahm, Melanie, Peters, David, Ellenberger, Uwe K, Zettl, Paulus S, Rommer, Alexander, Stahmann, Jörg, Bätzing
Publikováno v:
Multiple Sclerosis and Related Disorders. 59:103534
This study aimed to describe recent developments of multiple sclerosis (MS) prevalence in Germany and to assess utilization patterns of disease-modifying drugs (DMDs).We used nationwide outpatient claims data of the statutory health insurance (SHI) f